Clinical trial
Perillyl Alcohol in Treating Patients With Refractory Cancer
NCT00002862 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00002862 |
|---|---|
| Title | Perillyl Alcohol in Treating Patients With Refractory Cancer |
| Official title | A PHASE I STUDY OF PERILLYL ALCOHOL IN PATIENTS WITH REFRACTORY MALIGNANCIES (NSC #641066) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | perillyl alcohol |
| Enrollment | 25 |
| Start date | Oct 1, 1996 |
| Primary completion | Apr 1, 2001 |
| First posted | Jul 19, 2004 |
| Last update posted | Feb 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: